Potential Epigenetic Effects of Human Milk on Infants' Neurodevelopment.
Giannoula GialeliOurania PanagopoulouGeorgios LiosisTania SiahanidouPublished in: Nutrients (2023)
The advantages of human milk feeding, especially in preterm babies, are well recognized. Infants' feeding with breast milk lowers the likelihood of developing a diverse range of non-communicable diseases later in life and it is also associated with improved neurodevelopmental outcomes. Although the precise mechanisms through which human milk feeding is linked with infants' neurodevelopment are still unknown, potential epigenetic effects of breast milk through its bioactive components, including non-coding RNAs, stem cells and microbiome, could at least partly explain this association. Micro- and long-non-coding RNAs, enclosed in milk exosomes, as well as breast milk stem cells, survive digestion, reach the circulation and can cross the blood-brain barrier. Certain non-coding RNAs potentially regulate genes implicated in brain development and function, whereas nestin-positive stem cells can possibly differentiate into neural cells or/and act as epigenetic regulators in the brain. Furthermore, breast milk microbiota contributes to the establishment of infant's gut microbiome, which is implicated in brain development via epigenetic modifications and key molecules' regulation. This narrative review provides an updated analysis of the relationship between breast milk feeding and infants' neurodevelopment via epigenetics, pointing out how breast milk's bioactive components could have an impact on the neurodevelopment of both full-term and preterm babies.
Keyphrases
- human milk
- stem cells
- low birth weight
- preterm infants
- dna methylation
- gestational age
- preterm birth
- long non coding rna
- gene expression
- resting state
- white matter
- cell therapy
- genome wide
- cerebral ischemia
- functional connectivity
- induced apoptosis
- mesenchymal stem cells
- poor prognosis
- brain injury
- transcription factor
- cell proliferation
- metabolic syndrome
- type diabetes
- bone marrow
- blood brain barrier
- anaerobic digestion
- congenital heart disease
- risk assessment
- subarachnoid hemorrhage